{"id":40996,"date":"2026-07-21T22:33:00","date_gmt":"2026-07-21T20:33:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=2ab2aa47093bec91b0fe8128f8bb3153"},"modified":"2026-07-21T22:33:00","modified_gmt":"2026-07-21T20:33:00","slug":"rapid-medical-announces-fda-clearance-of-drivewire-35-and-first-stroke-cases","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=40996","title":{"rendered":"Rapid Medical Announces FDA Clearance of DRIVEWIRE\u2122 35 and First Stroke Cases"},"content":{"rendered":"

\nFirst steerable 0.035-inch guidewire combines controlled tip deflection and distal support to accelerate catheter access; builds on nearly 5,000 DRIVEWIRE\u2122 24 cases<\/i><\/p><\/a><\/a><\/a><\/a>

SEATTLE & YOKNEAM, Israel--(BUSINESS WIRE)--#DRIVEWIRE<\/a>--Rapid Medical\u2122<\/a>, a leading developer of advanced stroke treatment devices, today announced U.S. Food and Drug Administration clearance of DRIVEWIRE\u2122 35<\/a>, the first steerable 0.035-inch guidewire designed to help physicians reach the treatment site quickly and precisely during stroke and other intravascular procedures. The clearance was announced at the Society of NeuroInterventional Surgery\u2019s (SNIS) 23rd Annual Meeting & Fellows Course.<\/p>

\nJeremy Rempel, MD<\/a>, of the University of Alberta Hospital in Edmonton, Canada, performed the first clinical cases worldwide, including successfully navigating catheters to treat an intracranial occlusion without crossing the clot.<\/p>

\n\u201cIn stroke, every minute matters,\u201d said Dr. Rempel. \u201cDRIVEWIRE 35 lets me shape the wire inside the vessel and precisely direct the catheter toward the clot without pushing the wire through it. Its steering and support help me navigate around vessel edges, bypass the ledge effect, and potentially reduce the need for additional devices. This can simplify access and save valuable time.\u201d<\/p>

\nDRIVEWIRE 35 is a shapeable wire that adds active steering to compatible catheters. By deflecting and reshaping the wire inside the vessel, physicians can articulate the catheter tip and direct it through complex anatomy\u2014effectively turning a conventional catheter into a steerable system. This control helps physicians select vessels, navigate challenging anatomy, bypass the ledge effect, and reach the treatment site with fewer nested devices.<\/p>

\n\u201cThe nearly 5,000 DRIVEWIRE 24 cases demonstrate the growing role of steerable access,\u201d said James Romero<\/a>, President of the Americas at Rapid Medical. \u201cDRIVEWIRE 35 brings that same active control to a larger platform, helping physicians navigate complex anatomy across neurovascular and peripheral vascular procedures.\u201d DRIVEWIRE 35 is the third steerable guidewire in Rapid Medical\u2019s expanding portfolio.<\/p>

\nAbout Rapid Medical\n<\/b>Rapid Medical<\/a> expands what\u2019s possible in neurovascular treatment by pioneering advanced interventional devices that treat ischemic and hemorrhagic stroke. Utilizing proprietary manufacturing techniques, Rapid Medical\u2019s products are remotely adjustable and fully visible. This enables physicians to respond in real-time to the anatomy and tailor their approach to each patient for better procedural outcomes. Product families include TIGERTRIEVER\u2122<\/a>, COMANECI\u2122<\/a>, and DRIVEWIRE\u2122<\/a>. Not all products are available in all geographies. More information is available at www.rapid-medical.com<\/a>.<\/p> Contacts<\/b>

\nRonen Eckhouse\n+972-72-2503331\nronen@rapid-medical.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

First steerable 0.035-inch guidewire combines controlled tip deflection and distal support to accelerate catheter access; builds on nearly 5,000 DRIVEWIRE\u2122 24 casesSEATTLE & YOKNEAM, Israel–(BUSINESS WIRE)–#DRIVEWIRE–Rapid Medical\u2122, a leading devel…<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-40996","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/40996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=40996"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/40996\/revisions"}],"predecessor-version":[{"id":41004,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/40996\/revisions\/41004"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=40996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=40996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=40996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}